Provider
hybrid Cash pay onlyHims & Hers: what it costs and how it works
Hims & Hers is a publicly listed telehealth company (NYSE: HIMS) with 2.89 million subscribers and $753 million of revenue in the second quarter of 2026. It sells branded Wegovy, Zepbound, Ozempic and Foundayo, and it also compounds.
The pricing and the detail
Its prices are two charges rather than one: a membership at $39 for the first month and $149 a month after that, and then the medication on top, from $149 a month for the Wegovy pill or Foundayo to $299 for branded Zepbound in either the KwikPen or the vial. It listed branded Mounjaro at more than six times that in August 2026 and no longer sells it at all. Hims sells no medication at all without the membership. Its annual report states that it uses only 503A compounding pharmacies for compounded GLP-1s, and that most prescriptions are filled by pharmacies it owns outright. The same filings disclose two FDA warning letters in September 2025 about statements on its websites regarding compounded semaglutide, an SEC investigation into its public statements on the same subject, and patent litigation brought by Novo Nordisk alleging willful infringement.
- Medication from
- $199
- Audit complete
- 5/5 checks
- Evidence attached
- 6 cited sources
We earn a referral fee from some providers. Not Hims & Hers. It never changes our audit. How we make money
Is Hims & Hers legitimate? What we checked
Checked August 30, 2026
- Dispensing pharmacy
- 503A
- LegitScript certified
- Yes
- Price shown before intake
- Yes
- Cancel online
- Yes
- Prescriber disclosed
- Yes
- Pharmacy named
- Its own wholly-owned pharmacies, plus contracted partner pharmacies
What it costs
Care, per month
$149
Medication, per month
$199 to $299
- Semaglutide Wegovy pen, medication only
- $199 /mo
- Tirzepatide Zepbound KwikPen or vial, medication only. Hims sells no Mounjaro
- $299 /mo
Membership only. $39 for the first month, then $149 a month. Medication is charged separately and there is no medication without the membership
Key facts
- Membership
- $39 the first month, then $149 a month. No medication is sold without it
- Wegovy pen
- $199 a month, medication only
- Branded Zepbound
- $299 a month for the KwikPen or the vial, medication only
- Compounding pathway
- 503A only, stated in its 10-K
- Who dispenses
- Its own wholly-owned pharmacies, plus partner pharmacies
- Open regulatory matters
- Two FDA warning letters and an SEC investigation
- Subscribers
- 2.89 million, Q2 2026
Compared head to head
Sources
Every claim above is checked against the primary text, and the date is the day we last opened it.
-
1
NovoCare Pharmacy
Novo Nordisk Primary text read and checked Checked August 26, 2026
-
2
Hims & Hers Health, Inc. Form 10-K for the year ended 31 December 2025
U.S. Securities and Exchange Commission (EDGAR) Primary text read and checked Checked August 25, 2026
-
3
Hims & Hers Health, Inc. Form 10-Q for the quarter ended 30 June 2026
U.S. Securities and Exchange Commission (EDGAR) Primary text read and checked Checked August 25, 2026
-
4
LegitScript certification seals, served from LegitScript's own CDN
LegitScript Primary text read and checked Checked August 26, 2026
-
5
Weight Loss Care for Men, Built to Last
Hims & Hers Health, Inc. Primary text read and checked Checked August 26, 2026
-
6
Clinical excellence
Hims & Hers Health, Inc. Primary text read and checked Checked August 30, 2026